Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 9, 1997, Pages 1867-1870

  Visalli, Melissa A ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; DIRITHROMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; ROXITHROMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0030779918     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.9.1867     Document Type: Article

References (20)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
2. Barry, A. L., M. A. Pfaller, and P. C. Fuchs. 1993. Dirithromycin disc susceptibility tests: interpretive criteria and quality control parameters. J. Antimicrob. Chemother. 31(Suppl. C):27-37.
3. Barry, A. L., M. A. Pfaller, P. C. Fuchs, and R. R. Packer. 1994. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob. Agents Chemother. 38:2419-2425.
4. Bauernfeind, A. 1993. In-vitro activity of dirithromycin in comparison with other new and established macrolides. J. Antimicrob. Chemother. 31(Suppl. C):39-49.
5. Bergogne-Bérézin, E. 1993. Tissue distribution of dirithromycin: comparison with erythromycin. J. Antimicrob. Chemother. 31(Suppl. C):77-87.
6. Block, S., C. J. Harrison, J. A. Hedrick, R. D. Tyler, R. A. Smith, E. Keegan, and S. A. Chartrand. 1995. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr. Infect. Dis. J. 14:751-759.
7. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
8. Counter, F. T., P. W. Ensminger, D. A. Preston, C.-Y. E. Wu, J. M. Greene, A. M. Felty-Duckworth, J. W. Paschal, and H. A. Kirst. 1991. Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY 237216), a new macrolide antibiotic derived from erythromycin. Antimicrob. Agents Chemother. 35:1116-1126.
9. Doern, G. V., A. Brueggemann, H. P. Holley, and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40: 1208-1213.
10. Ednie, L. M., M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum. 1996. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob. Agents Chemother. 40:1950-1952.
11. Fasola, E. L., S. Bajaksouzian, P. C. Appelbaum, and M. R. Jacobs. 1997. Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods. Antimicrob. Agents Chemother. 41:129-134.
12. Friedland, I. R., and G. H. McCracken, Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
13. Geslin, P., A. Fremaux, G. Sissia, C. Spicq, and A. Aberrane. 1994. Epidémiologie de la résistance aux antibiotiques de Streptococcus pneumoniae en France. Réseau national de surveillance (1984-1993). Med. Mal. Infect. 24:948-961.
14. Jacobs, M. R. 1992. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 15:119-127.
15. Liñares, J., T. Alonso, J. Ayats, F. Alcaide, F. Tubau, J. Hernandez, and R. Martín. 1991. In vitro activity of 7 macrolide antibiotics and 9 other antimicrobial agents against penicillin-resistant pneumococci, abstr. 191, p. 130. In Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
16. Mason, E. O., Jr., S. L. Kaplan, L. B. Lamberth, and J. Tillman. 1992. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob. Agents Chemother. 36:1703-1707.
17. Munoz, R., T. J. Coffey, M. Daniels, C. G. Dowson, G. Laible, J. Casal, R. Hakenbeck, M. Jacobs, J. M. Musser, B. G. Spratt, and A. Tomasz. 1991. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J. Infect. Dis. 164:302-306.
18. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS publication M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
19. Nelson, C. T., E. O. Mason, Jr., and S. L. Kaplan. 1994. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr. Infect. Dis. J. 13:585-589.
20. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1994. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin and vancomycin by using time-kill methodology. Antimicrob. Agents Chemother. 38:2065-2072.